Global RNAi for Therapeutic Market Professional Survey Report 2017

December 2017 | 116 pages | ID: GE7EAB86AF3EN
QYResearch

Abstracts

This report studies RNAi for Therapeutic in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Alnylam Pharmaceuticals
• Arbutus Biopharma (Tekmira)
• Arrowhead Research
• Dicerna Pharmaceuticals
• Mirna Therapeutics
• Quark Pharmaceuticals
• RXi Pharmaceuticals
• Silence Therapeutics
• Benitec Biopharma
• Miragen Therapeutics
• Sylentis
• Gradalis
• Sirnaomics
• Silenseed
• Arcturus Therapeutics
• Ariz Biopharma
• Celsion Corporation
• Ascletis Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• siRNA
• miRNA
• shRNA

By Application, the market can be split into

• Cancer
• Cardiovascular
• HBV
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global RNAi for Therapeutic Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RNAI FOR THERAPEUTIC

1.1 Definition and Specifications of RNAi for Therapeutic
  1.1.1 Definition of RNAi for Therapeutic
  1.1.2 Specifications of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic
  1.2.1 siRNA
  1.2.2 miRNA
  1.2.3 shRNA
1.3 Applications of RNAi for Therapeutic
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 HBV
  1.3.4 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RNAI FOR THERAPEUTIC

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of RNAi for Therapeutic
2.3 Manufacturing Process Analysis of RNAi for Therapeutic
2.4 Industry Chain Structure of RNAi for Therapeutic

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RNAI FOR THERAPEUTIC

3.1 Capacity and Commercial Production Date of Global RNAi for Therapeutic Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global RNAi for Therapeutic Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global RNAi for Therapeutic Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global RNAi for Therapeutic Major Manufacturers in 2016

4 GLOBAL RNAI FOR THERAPEUTIC OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global RNAi for Therapeutic Capacity and Growth Rate Analysis
  4.2.2 2016 RNAi for Therapeutic Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global RNAi for Therapeutic Sales and Growth Rate Analysis
  4.3.2 2016 RNAi for Therapeutic Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global RNAi for Therapeutic Sales Price
  4.4.2 2016 RNAi for Therapeutic Sales Price Analysis (Company Segment)

5 RNAI FOR THERAPEUTIC REGIONAL MARKET ANALYSIS

5.1 North America RNAi for Therapeutic Market Analysis
  5.1.1 North America RNAi for Therapeutic Market Overview
  5.1.2 North America 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.1.4 North America 2016 RNAi for Therapeutic Market Share Analysis
5.2 China RNAi for Therapeutic Market Analysis
  5.2.1 China RNAi for Therapeutic Market Overview
  5.2.2 China 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.2.4 China 2016 RNAi for Therapeutic Market Share Analysis
5.3 Europe RNAi for Therapeutic Market Analysis
  5.3.1 Europe RNAi for Therapeutic Market Overview
  5.3.2 Europe 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.3.4 Europe 2016 RNAi for Therapeutic Market Share Analysis
5.4 Southeast Asia RNAi for Therapeutic Market Analysis
  5.4.1 Southeast Asia RNAi for Therapeutic Market Overview
  5.4.2 Southeast Asia 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.4.4 Southeast Asia 2016 RNAi for Therapeutic Market Share Analysis
5.5 Japan RNAi for Therapeutic Market Analysis
  5.5.1 Japan RNAi for Therapeutic Market Overview
  5.5.2 Japan 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.5.4 Japan 2016 RNAi for Therapeutic Market Share Analysis
5.6 India RNAi for Therapeutic Market Analysis
  5.6.1 India RNAi for Therapeutic Market Overview
  5.6.2 India 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E RNAi for Therapeutic Sales Price Analysis
  5.6.4 India 2016 RNAi for Therapeutic Market Share Analysis

6 GLOBAL 2012-2017E RNAI FOR THERAPEUTIC SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E RNAi for Therapeutic Sales by Type
6.2 Different Types of RNAi for Therapeutic Product Interview Price Analysis
6.3 Different Types of RNAi for Therapeutic Product Driving Factors Analysis
  6.3.1 siRNA of RNAi for Therapeutic Growth Driving Factor Analysis
  6.3.2 miRNA of RNAi for Therapeutic Growth Driving Factor Analysis
  6.3.3 shRNA of RNAi for Therapeutic Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RNAI FOR THERAPEUTIC SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E RNAi for Therapeutic Consumption by Application
7.2 Different Application of RNAi for Therapeutic Product Interview Price Analysis
7.3 Different Application of RNAi for Therapeutic Product Driving Factors Analysis
  7.3.1 Cancer of RNAi for Therapeutic Growth Driving Factor Analysis
  7.3.2 Cardiovascular of RNAi for Therapeutic Growth Driving Factor Analysis
  7.3.3 HBV of RNAi for Therapeutic Growth Driving Factor Analysis
  7.3.4 Other of RNAi for Therapeutic Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RNAI FOR THERAPEUTIC

8.1 Alnylam Pharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Alnylam Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Alnylam Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.2 Arbutus Biopharma (Tekmira)
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Arbutus Biopharma (Tekmira) 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Arbutus Biopharma (Tekmira) 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.3 Arrowhead Research
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Arrowhead Research 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Arrowhead Research 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.4 Dicerna Pharmaceuticals
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Dicerna Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Dicerna Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.5 Mirna Therapeutics
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Mirna Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Mirna Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.6 Quark Pharmaceuticals
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Quark Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Quark Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.7 RXi Pharmaceuticals
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 RXi Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 RXi Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.8 Silence Therapeutics
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Silence Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Silence Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.9 Benitec Biopharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Benitec Biopharma 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Benitec Biopharma 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.10 Miragen Therapeutics
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Miragen Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Miragen Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
8.11 Sylentis
8.12 Gradalis
8.13 Sirnaomics
8.14 Silenseed
8.15 Arcturus Therapeutics
8.16 Ariz Biopharma
8.17 Celsion Corporation
8.18 Ascletis Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF RNAI FOR THERAPEUTIC MARKET

9.1 Global RNAi for Therapeutic Market Trend Analysis
  9.1.1 Global 2017-2022 RNAi for Therapeutic Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 RNAi for Therapeutic Sales Price Forecast
9.2 RNAi for Therapeutic Regional Market Trend
  9.2.1 North America 2017-2022 RNAi for Therapeutic Consumption Forecast
  9.2.2 China 2017-2022 RNAi for Therapeutic Consumption Forecast
  9.2.3 Europe 2017-2022 RNAi for Therapeutic Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 RNAi for Therapeutic Consumption Forecast
  9.2.5 Japan 2017-2022 RNAi for Therapeutic Consumption Forecast
  9.2.6 India 2017-2022 RNAi for Therapeutic Consumption Forecast
9.3 RNAi for Therapeutic Market Trend (Product Type)
9.4 RNAi for Therapeutic Market Trend (Application)

10 RNAI FOR THERAPEUTIC MARKETING TYPE ANALYSIS

10.1 RNAi for Therapeutic Regional Marketing Type Analysis
10.2 RNAi for Therapeutic International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of RNAi for Therapeutic by Region
10.4 RNAi for Therapeutic Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RNAI FOR THERAPEUTIC

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RNAI FOR THERAPEUTIC MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of RNAi for Therapeutic
Table Product Specifications of RNAi for Therapeutic
Table Classification of RNAi for Therapeutic
Figure Global Production Market Share of RNAi for Therapeutic by Type in 2016
Figure siRNA Picture
Table Major Manufacturers of siRNA
Figure miRNA Picture
Table Major Manufacturers of miRNA
Figure shRNA Picture
Table Major Manufacturers of shRNA
Table Applications of RNAi for Therapeutic
Figure Global Consumption Volume Market Share of RNAi for Therapeutic by Application in 2016
Figure Cancer Examples
Table Major Consumers in Cancer
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure HBV Examples
Table Major Consumers in HBV
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of RNAi for Therapeutic by Regions
Figure North America RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Figure China RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Figure Europe RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Figure Southeast Asia RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Figure Japan RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Figure India RNAi for Therapeutic Market Size (Million USD) (2012-2022)
Table RNAi for Therapeutic Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of RNAi for Therapeutic in 2016
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure Industry Chain Structure of RNAi for Therapeutic
Table Capacity and Commercial Production Date of Global RNAi for Therapeutic Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global RNAi for Therapeutic Major Manufacturers in 2016
Table R&D Status and Technology Source of Global RNAi for Therapeutic Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global RNAi for Therapeutic Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of RNAi for Therapeutic 2012-2017
Figure Global 2012-2017E RNAi for Therapeutic Market Size (Volume) and Growth Rate
Figure Global 2012-2017E RNAi for Therapeutic Market Size (Value) and Growth Rate
Table 2012-2017E Global RNAi for Therapeutic Capacity and Growth Rate
Table 2016 Global RNAi for Therapeutic Capacity (K Units) List (Company Segment)
Table 2012-2017E Global RNAi for Therapeutic Sales (K Units) and Growth Rate
Table 2016 Global RNAi for Therapeutic Sales (K Units) List (Company Segment)
Table 2012-2017E Global RNAi for Therapeutic Sales Price (USD/Unit)
Table 2016 Global RNAi for Therapeutic Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure North America 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure North America 2016 RNAi for Therapeutic Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure China 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure China 2016 RNAi for Therapeutic Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure Europe 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure Europe 2016 RNAi for Therapeutic Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure Southeast Asia 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure Southeast Asia 2016 RNAi for Therapeutic Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure Japan 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure Japan 2016 RNAi for Therapeutic Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of RNAi for Therapeutic 2012-2017E
Figure India 2012-2017E RNAi for Therapeutic Sales Price (USD/Unit)
Figure India 2016 RNAi for Therapeutic Sales Market Share
Table Global 2012-2017E RNAi for Therapeutic Sales (K Units) by Type
Table Different Types RNAi for Therapeutic Product Interview Price
Table Global 2012-2017E RNAi for Therapeutic Sales (K Units) by Application
Table Different Application RNAi for Therapeutic Product Interview Price
Table Alnylam Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Alnylam Pharmaceuticals RNAi for Therapeutic Business Region Distribution
Table Arbutus Biopharma (Tekmira) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Business Region Distribution
Table Arrowhead Research Information List
Table Product A Overview
Table Product B Overview
Table 2015 Arrowhead Research RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arrowhead Research RNAi for Therapeutic Business Region Distribution
Table Dicerna Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Dicerna Pharmaceuticals RNAi for Therapeutic Business Region Distribution
Table Mirna Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Mirna Therapeutics RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Mirna Therapeutics RNAi for Therapeutic Business Region Distribution
Table Quark Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Quark Pharmaceuticals RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Quark Pharmaceuticals RNAi for Therapeutic Business Region Distribution
Table RXi Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 RXi Pharmaceuticals RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 RXi Pharmaceuticals RNAi for Therapeutic Business Region Distribution
Table Silence Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Silence Therapeutics RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Silence Therapeutics RNAi for Therapeutic Business Region Distribution
Table Benitec Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Benitec Biopharma RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Benitec Biopharma RNAi for Therapeutic Business Region Distribution
Table Miragen Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Miragen Therapeutics RNAi for Therapeutic Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Miragen Therapeutics RNAi for Therapeutic Business Region Distribution
Table Sylentis Information List
Table Gradalis Information List
Table Sirnaomics Information List
Table Silenseed Information List
Table Arcturus Therapeutics Information List
Table Ariz Biopharma Information List
Table Celsion Corporation Information List
Table Ascletis Pharmaceuticals Information List
Figure Global 2017-2022 RNAi for Therapeutic Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 RNAi for Therapeutic Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 RNAi for Therapeutic Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 RNAi for Therapeutic Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of RNAi for Therapeutic by Type 2017-2022
Table Global Consumption Volume (K Units) of RNAi for Therapeutic by Application 2017-2022
Table Traders or Distributors with Contact Information of RNAi for Therapeutic by Region